Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

InnoCare Pharma Limited INCPF

Full chart Compare
Set alert

Price alert · INCPF

All alert types
1.60 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

1.60 Day range 1.60
1.55 52-week range 2.31
YTD
-21.95%
1 year
-50.92%

Financial health

Altman Z-Score

3.75 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 1
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 3
  • P/B 3

Valuation

P/E 39.8×
FY 2017: -89.2×FY 2018: -57.8×FY 2019: -21.3×FY 2020: -60.4×FY 2021: -566×FY 2022: -37.5×FY 2023: -62.5×FY 2024: -91.5×FY 2025: 39.8×
FY 2017 5y median -62.5× FY 2025
P/S 11.0×
FY 2017: 295393×FY 2018: 19691×FY 2019: 25854×FY 2020: 17126×FY 2021: 35.0×FY 2022: 53.2×FY 2023: 53.4×FY 2024: 39.9×FY 2025: 11.0×
FY 2017 5y median 39.9× FY 2025
P/B 3.3×
FY 2017: -76.8×FY 2018: -35.2×FY 2019: -10.7×FY 2020: 7.5×FY 2021: 6.5×FY 2022: 4.4×FY 2023: 5.5×FY 2024: 6.0×FY 2025: 3.3×
FY 2017 5y median 5.5× FY 2025
P/FCF 193×
FY 2017: -593×FY 2018: -843×FY 2019: -257×FY 2020: -55.1×FY 2021: -3321391×FY 2022: -35.5×FY 2023: -42.6×FY 2024: -90.7×FY 2025: 193×
FY 2017 5y median -42.6× FY 2025
EV/EBITDA 35.6×
FY 2017: -90.1×FY 2018: -56.6×FY 2019: -14.5×FY 2020: -37.6×FY 2021: -214×FY 2022: -31.9×FY 2023: -63.1×FY 2024: -113×FY 2025: 35.6×
FY 2017 5y median -63.1× FY 2025
EV/Sales 8.6×
FY 2017: 296369×FY 2018: 19167×FY 2019: 24927×FY 2020: 15076×FY 2021: 30.6×FY 2022: 41.3×FY 2023: 44.1×FY 2024: 35.0×FY 2025: 8.6×
FY 2017 5y median 35.0× FY 2025
FCF Yield 0.5%
FY 2017: -0.2%FY 2018: -0.1%FY 2019: -0.4%FY 2020: -1.8%FY 2021: -0.0%FY 2022: -2.8%FY 2023: -2.3%FY 2024: -1.1%FY 2025: 0.5%
FY 2017 5y median -1.1% FY 2025

Profitability

Gross Margin 87.6%
FY 2017: 100.0%FY 2018: 100.0%FY 2019: -2606.1%FY 2020: 100.0%FY 2021: 93.7%FY 2022: 77.1%FY 2023: 82.6%FY 2024: 86.3%FY 2025: 87.6%
FY 2017 5y median 86.3% FY 2025
Operating Margin 19.2%
FY 2017: -333468.6%FY 2018: -34255.6%FY 2019: -172669.2%FY 2020: -40981.4%FY 2021: -17.4%FY 2022: -123.2%FY 2023: -88.2%FY 2024: -52.1%FY 2025: 19.2%
FY 2017 5y median -52.1% FY 2025
Net Margin 27.2%
FY 2017: -335033.3%FY 2018: -34010.5%FY 2019: -171723.2%FY 2020: -28694.6%FY 2021: -6.2%FY 2022: -141.8%FY 2023: -85.5%FY 2024: -43.7%FY 2025: 27.2%
FY 2017 5y median -43.7% FY 2025
ROE 8.1%
FY 2017: 87.2%FY 2018: 60.8%FY 2019: 71.3%FY 2020: -12.6%FY 2021: -1.2%FY 2022: -11.7%FY 2023: -8.8%FY 2024: -6.6%FY 2025: 8.1%
FY 2017 5y median -6.6% FY 2025
ROIC 4.5%
FY 2017: -419.3%FY 2018: -25.1%FY 2019: -83.9%FY 2020: -12.6%FY 2021: -2.6%FY 2022: -8.1%FY 2023: -7.2%FY 2024: -6.1%FY 2025: 4.5%
FY 2017 5y median -6.1% FY 2025
ROA 5.8%
FY 2017: -318.2%FY 2018: -25.0%FY 2019: -81.9%FY 2020: -8.6%FY 2021: -0.9%FY 2022: -8.6%FY 2023: -6.4%FY 2024: -4.7%FY 2025: 5.8%
FY 2017 5y median -4.7% FY 2025

Growth (YoY)

Revenue 127.6%
FY 2017: 0.0%FY 2018: 1485.3%FY 2019: -22.9%FY 2020: 9.4%FY 2021: 76368.7%FY 2022: -40.0%FY 2023: 18.1%FY 2024: 36.7%FY 2025: 127.6%
FY 2017 FY 2025
Operating Income 183.8%
FY 2017: 0.0%FY 2018: -62.8%FY 2019: -288.7%FY 2020: 74.0%FY 2021: 67.6%FY 2022: -325.4%FY 2023: 15.5%FY 2024: 19.3%FY 2025: 183.8%
FY 2017 FY 2025
EPS (diluted) 238.5%
FY 2017: 0.0%FY 2018: -63.0%FY 2019: -288.6%FY 2020: 76.6%FY 2021: 90.8%FY 2022: -1539.3%FY 2023: 38.3%FY 2024: 29.7%FY 2025: 238.5%
FY 2017 FY 2025
Free Cash Flow 129.5%
FY 2017: 0.0%FY 2018: 25.6%FY 2019: -231.7%FY 2020: -238.4%FY 2021: 100.0%FY 2022: -8507909.1%FY 2023: 1.1%FY 2024: 52.1%FY 2025: 129.5%
FY 2017 FY 2025

Financial Health

Current Ratio 5.8×
FY 2017: 0.5×FY 2018: 28.5×FY 2019: 36.7×FY 2020: 39.2×FY 2021: 19.5×FY 2022: 4.5×FY 2023: 4.2×FY 2024: 7.4×FY 2025: 5.8×
FY 2017 5y median 5.8× FY 2025
Quick Ratio 5.7×
FY 2017: 0.5×FY 2018: 28.5×FY 2019: 36.6×FY 2020: 39.2×FY 2021: 19.5×FY 2022: 4.4×FY 2023: 4.1×FY 2024: 7.3×FY 2025: 5.7×
FY 2017 5y median 5.7× FY 2025
Debt / Equity 0.2×
FY 2017: -0.3×FY 2018: -1.1×FY 2019: -0.4×FY 2020: 0.4×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.2×
FY 2017 5y median 0.2× FY 2025
Net Debt / EBITDA -9.8×
FY 2017: -0.3×FY 2018: 1.5×FY 2019: 0.5×FY 2020: 5.1×FY 2021: 31.3×FY 2022: 9.2×FY 2023: 13.3×FY 2024: 15.8×FY 2025: -9.8×
FY 2017 5y median 13.3× FY 2025
Interest Coverage 8.2×
FY 2017: -141×FY 2018: -383×FY 2019: -2296×FY 2020: -491×FY 2021: -68.5×FY 2022: -45.2×FY 2023: -18.6×FY 2024: -15.6×FY 2025: 8.2×
FY 2017 5y median -18.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.9%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -0.2%FY 2024: -82.4%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31